152 related articles for article (PubMed ID: 15107804)
1. Prostate cancer invasion is influenced more by expression of a CD44 isoform including variant 9 than by Muc18.
Omara-Opyene AL; Qiu J; Shah GV; Iczkowski KA
Lab Invest; 2004 Jul; 84(7):894-907. PubMed ID: 15107804
[TBL] [Abstract][Full Text] [Related]
2. Isolation and characterization of the major form of human MUC18 cDNA gene and correlation of MUC18 over-expression in prostate cancer cell lines and tissues with malignant progression.
Wu GJ; Wu MW; Wang SW; Liu Z; Qu P; Peng Q; Yang H; Varma VA; Sun QC; Petros JA; Lim SD; Amin MB
Gene; 2001 Nov; 279(1):17-31. PubMed ID: 11722842
[TBL] [Abstract][Full Text] [Related]
3. Expression of a human cell adhesion molecule, MUC18, in prostate cancer cell lines and tissues.
Wu GJ; Varma VA; Wu MW; Wang SW; Qu P; Yang H; Petros JA; Lim SD; Amin MB
Prostate; 2001 Sep; 48(4):305-15. PubMed ID: 11536311
[TBL] [Abstract][Full Text] [Related]
4. Prostate cancer overexpresses CD44 variants 7-9 at the messenger RNA and protein level.
Iczkowski KA; Bai S; Pantazis CG
Anticancer Res; 2003; 23(4):3129-40. PubMed ID: 12926045
[TBL] [Abstract][Full Text] [Related]
5. Ectopical expression of human MUC18 increases metastasis of human prostate cancer cells.
Wu GJ; Peng Q; Fu P; Wang SW; Chiang CF; Dillehay DL; Wu MW
Gene; 2004 Mar; 327(2):201-13. PubMed ID: 14980717
[TBL] [Abstract][Full Text] [Related]
6. Stromal hyaluronan interaction with epithelial CD44 variants promotes prostate cancer invasiveness by augmenting expression and function of hepatocyte growth factor and androgen receptor.
Ghatak S; Hascall VC; Markwald RR; Misra S
J Biol Chem; 2010 Jun; 285(26):19821-32. PubMed ID: 20200161
[TBL] [Abstract][Full Text] [Related]
7. Paracrine calcitonin in prostate cancer is linked to CD44 variant expression and invasion.
Iczkowski KA; Omara-Opyene AL; Kulkarni TR; Pansara M; Shah GV
Anticancer Res; 2005; 25(3B):2075-83. PubMed ID: 16158948
[TBL] [Abstract][Full Text] [Related]
8. Decreased levels of CD44 protein and mRNA in prostate carcinoma. Correlation with tumor grade and ploidy.
Kallakury BV; Yang F; Figge J; Smith KE; Kausik SJ; Tacy NJ; Fisher HA; Kaufman R; Figge H; Ross JS
Cancer; 1996 Oct; 78(7):1461-9. PubMed ID: 8839552
[TBL] [Abstract][Full Text] [Related]
9. A fully human antimelanoma cellular adhesion molecule/MUC18 antibody inhibits spontaneous pulmonary metastasis of osteosarcoma cells in vivo.
McGary EC; Heimberger A; Mills L; Weber K; Thomas GW; Shtivelband M; Lev DC; Bar-Eli M
Clin Cancer Res; 2003 Dec; 9(17):6560-6. PubMed ID: 14695161
[TBL] [Abstract][Full Text] [Related]
10. Direct correlation between MUC18 expression and metastatic potential of human melanoma cells.
Luca M; Hunt B; Bucana CD; Johnson JP; Fidler IJ; Bar-Eli M
Melanoma Res; 1993 Feb; 3(1):35-41. PubMed ID: 8471835
[TBL] [Abstract][Full Text] [Related]
11. Stable alterations of CD44 isoform expression in prostate cancer cells decrease invasion and growth and alter ligand binding and chemosensitivity.
Yang K; Tang Y; Habermehl GK; Iczkowski KA
BMC Cancer; 2010 Jan; 10():16. PubMed ID: 20074368
[TBL] [Abstract][Full Text] [Related]
12. The role of a new CD44st in increasing the invasion capability of the human breast cancer cell line MCF-7.
Fang XJ; Jiang H; Zhao XP; Jiang WM
BMC Cancer; 2011 Jul; 11():290. PubMed ID: 21749678
[TBL] [Abstract][Full Text] [Related]
13. The influence of CD44v3-v10 on adhesion, invasion and MMP-14 expression in prostate cancer cells.
Harrison GM; Davies G; Martin TA; Mason MD; Jiang WG
Oncol Rep; 2006 Jan; 15(1):199-206. PubMed ID: 16328056
[TBL] [Abstract][Full Text] [Related]
14. The prognostic value of CD44 isoforms in prostate cancer patients treated by radical prostatectomy.
Noordzij MA; van Steenbrugge GJ; Verkaik NS; Schröder FH; van der Kwast TH
Clin Cancer Res; 1997 May; 3(5):805-15. PubMed ID: 9815753
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of MUC18 correlates with the metastatic progression of mouse prostate adenocarcinoma in the TRAMP model.
Wu GJ; Fu P; Chiang CF; Huss WJ; Greenberg NM; Wu MW
J Urol; 2005 May; 173(5):1778-83. PubMed ID: 15821586
[TBL] [Abstract][Full Text] [Related]
16. MAP kinase pathways and calcitonin influence CD44 alternate isoform expression in prostate cancer cells.
Robbins EW; Travanty EA; Yang K; Iczkowski KA
BMC Cancer; 2008 Sep; 8():260. PubMed ID: 18793421
[TBL] [Abstract][Full Text] [Related]
17. MUC18, a marker of tumor progression in human melanoma, shows sequence similarity to the neural cell adhesion molecules of the immunoglobulin superfamily.
Lehmann JM; Riethmüller G; Johnson JP
Proc Natl Acad Sci U S A; 1989 Dec; 86(24):9891-5. PubMed ID: 2602381
[TBL] [Abstract][Full Text] [Related]
18. CD44 variant isoforms in head and neck squamous cell carcinoma progression.
Wang SJ; Wong G; de Heer AM; Xia W; Bourguignon LY
Laryngoscope; 2009 Aug; 119(8):1518-30. PubMed ID: 19507218
[TBL] [Abstract][Full Text] [Related]
19. Isolation and characterization of mouse MUC18 cDNA gene, and correlation of MUC18 expression in mouse melanoma cell lines with metastatic ability.
Yang H; Wang S; Liu Z; Wu MH; McAlpine B; Ansel J; Armstrong C; Wu G
Gene; 2001 Mar; 265(1-2):133-45. PubMed ID: 11255016
[TBL] [Abstract][Full Text] [Related]
20. Phenyl-methylene hydantoins alter CD44-specific ligand binding of benign and malignant prostate cells and suppress CD44 isoform expression.
Yang K; Tang Y; Iczkowski KA
Am J Transl Res; 2010 Jan; 2(1):88-94. PubMed ID: 20182585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
